Foundation Medicine Announces Timing for Second Quarter 2017 Financial Results and Conference Call

Global Blood Therapeutics Expands Ongoing Phase 2a HOPE-KIDS 1 Study into Younger Pediatric Population

CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration

Decibel Therapeutics Announces Investment from GV to Expand Capabilities for Biological Target Identification in Hearing Loss and Tinnitus

Initial Results from Dana-Farber Cancer Institute Personalized Neoantigen Vaccine Published in Nature